Okla. Admin. Code § 317:30-5-47.6
Current through Vol. 41, No. 19, June 17, 2024
Section 317:30-5-47.6 - High-investment drugs - inpatient hospitals(a) The Oklahoma Health Care Authority (OHCA) designates certain high-investment drugs to be reimbursed separately pursuant to the Oklahoma Medicaid State Plan for members receiving services at an inpatient hospital.(b) The list of OHCA-designated high-investment drugs is set forth on the Pharmacy page of the OHCA website, which is available at https://okhca.org. This list may be updated as deemed necessary.(c) All high-investment drugs require prior authorization [refer to Oklahoma Administrative Code (OAC) 317:30-3-31] , and the inpatient hospital stay continues to be subject to applicable medical necessity criteria requirements [refer to OAC 317:30-3-1(f)] .(d) OHCA-designated high-investment drugs provided to eligible members, when treated in out-of-state inpatient hospitals, may be reimbursed in the same manner as in-state hospitals. Out-of-state inpatient hospitals must meet applicable out-of-state conditions of payment set forth in OAC 317:30-3-89 through 317:30-3-92, and in the Oklahoma Medicaid State Plan.Okla. Admin. Code § 317:30-5-47.6
Adopted by Oklahoma Register, Volume 37, Issue 19, June 15, 2020, eff. 5/14/2020Adopted by Oklahoma Register, Volume 38, Issue 23, August 16, 2021, eff. 9/1/2021